Digesting Dietary Data

Why are there so many contradictory nutrition studies, and how can they be improved?

Written byChristopher Gardner and Michael Stanton
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

© STUDIOM1/ISTOCKPHOTO.COMThe media commonly reports on what appear to be shocking contradictions and reversals in studies of diet and health. One day oat bran works for lowering cholesterol, the next day it doesn’t. One day the perils of butter drive up sales of margarines, until the risks of trans fats in margarine swing sales back in the other direction. For decades “low-fat” was the public-health mantra for weight loss, until a series of studies seemed to indicate “low-carb” was at least as effective. In truth, the findings from these studies are rarely as diametrically opposed to one another as the media portrays in a bid to capture the attention of their audience.

The recipe for creating controversy is built into the complexities linking food and nutrition to health and disease. The main ingredients include the target population, the type of diet or food or nutrient of interest, the dose, the outcome, and the duration. The general public wants to know whether “oat bran” is “healthy” to eat. For the nutrition scientist, that practical question is too broad to be answered effectively. If a study on the topic is to be effectively designed, proposed, funded, conducted, and published, it would first go through an almost torturous process of trying to make the question “answerable,” and this would involve narrowing the question to a set of specifics.

Ultimately and ideally, the general question about the healthfulness of oat bran ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies